AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
23:03
The spokesperson for the Kremlin, Dmitri Peskov, states that a summit between Putin, Trump, and Zelensky would only take place to formalize complex agreements.
22:43
Radu Miruță states that there is no information about the withdrawal of American soldiers from Romania, but on the contrary, their numbers have increased in the last year.
22:25
Ilie Bolojan congratulated the Romanian rowing team for the gold medal won in the 8+1 mixed event at the World Championship in Amsterdam.
22:01
NASA is launching the new space telescope, named after the first woman in a leadership position at the agency
21:30
Gabriela Ruse was defeated in the first round of the US Open by Jessica Pegula, ranked 3rd in WTA, with 6-3, 6-2
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Economy
Alphabet's shares fell by approximately 7%, marking the largest daily loss in the past year.
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
